These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 191476)
1. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation. Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476 [TBL] [Abstract][Full Text] [Related]
2. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2. Miller OV; Gorman RR J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467 [TBL] [Abstract][Full Text] [Related]
3. Platelet prostaglandin production and its implications. Smith JB; Ingerman CM; Silver MJ Adv Prostaglandin Thromboxane Res; 1976; 2():747-53. PubMed ID: 983875 [TBL] [Abstract][Full Text] [Related]
4. Malondialdehyde formation as an indicator of prostaglandin production by human platelets. Smith JB; Ingerman CM; Silver MJ J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533 [TBL] [Abstract][Full Text] [Related]
5. Platelet accumulation on collagen: drugs which inhibit arachidonic acid metabolism and affect intracellular cyclic AMP levels. Adams GA; Feuerstein IA Thromb Haemost; 1984 Aug; 52(1):45-9. PubMed ID: 6093281 [TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets. Malmsten C; Granström E; Samuelsson B Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797 [No Abstract] [Full Text] [Related]
7. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Maurice DH; Haslam RJ Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060 [TBL] [Abstract][Full Text] [Related]
8. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam. Romstedt K; Huzoor-Akbar Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062 [TBL] [Abstract][Full Text] [Related]
9. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism. Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816 [TBL] [Abstract][Full Text] [Related]
10. Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets. Matsuoka I; Suzuki T J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):341-53. PubMed ID: 6147364 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative. Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809 [TBL] [Abstract][Full Text] [Related]
12. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione. Gordge MP; Hothersall JS; Noronha-Dutra AA Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353 [TBL] [Abstract][Full Text] [Related]
13. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man]. Ardelt W Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100 [TBL] [Abstract][Full Text] [Related]
14. On the interrelationship of prostaglandin endoperoxide G2 and cyclic nucleotides in platelet function. Claesson HE; Malmsten C Eur J Biochem; 1977 Jun; 76(1):277-84. PubMed ID: 195812 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin. Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511 [TBL] [Abstract][Full Text] [Related]
16. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets. Salzman EW Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670 [TBL] [Abstract][Full Text] [Related]
17. The influence of prostaglandin endoperoxides on platelet ultrastructure. Gerrard JM; White JG Am J Pathol; 1975 Aug; 80(2):189-202. PubMed ID: 169697 [TBL] [Abstract][Full Text] [Related]
18. The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion. Gerrard JM; Townsend D; Stoddard S; Witkop CJ; White JG Am J Pathol; 1977 Jan; 86(1):99-116. PubMed ID: 188341 [TBL] [Abstract][Full Text] [Related]
19. Elevation of the cyclic GMP concentration in human platelets by sodium ascorbate and 5-hydroxytryptamine. Schoepflin GS; Pickett W; Austen KF; Goetzl EJ J Cyclic Nucleotide Res; 1977 Oct; 3(5):355-65. PubMed ID: 201683 [TBL] [Abstract][Full Text] [Related]
20. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions. Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]